CMT
VENTE TOTALE: 4 268 titres (~110 199,76 $ US)
- Insiders
- HELLMOLD RALPH O
- Total bought
- —
- Total sold
- $110,200
- Last activity
- 2026-08-07
- Last synced
-
2026-08-13 10:04:48
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-08-13
CMT's strong liquidity (Current Ratio > 3.0) provides a solvency buffer, but the sharp EPS deterioration (-55% YoY: $0.21 vs $0.47) combined with declining FCF conversion and rising capex signals a fundamentally…
The first sentence of the analysis written for CMT on 2026-08-13 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 17.4% | 17.6% | 18.0% | 13.9% | 13.4% | |
| Ebit Margin | 5.4% | 5.8% | 7.5% | 4.4% | 3.7% | |
| Ebitda Margin | 9.9% | 10.2% | 11.1% | 7.6% | 7.4% | |
| Operating Profit Margin | 5.2% | 5.5% | 7.4% | 4.8% | 3.6% | |
| Pretax Profit Margin | 5.4% | 5.8% | 7.2% | 3.9% | 2.9% | |
| Continuous Operations Profit Margin | 4.1% | 4.4% | 5.7% | 3.2% | 1.5% | |
| Net Profit Margin | 4.1% | 4.4% | 5.7% | 3.2% | 1.5% | |
| Bottom Line Profit Margin | 4.1% | 4.4% | 5.7% | 3.2% | 1.4% | |
| Current Ratio | 3.024 | 2.803 | 2.227 | 1.588 | 1.416 | |
| Quick Ratio | 2.447 | 2.303 | 1.750 | 1.118 | 0.943 | |
| Solvency Ratio | 0.337 | 0.429 | 0.447 | 0.292 | 0.188 | |
| Cash Ratio | 1.114 | 1.139 | 0.522 | 0.082 | 0.116 | |
| Price To Earnings Ratio | 15.305 | 10.810 | 7.819 | 9.021 | 15.473 | |
| Price To Earnings Growth Ratio | -1.064 | -0.305 | 0.121 | 0.056 | -0.353 | |
| Forward Price To Earnings Growth Ratio | -1.064 | -0.305 | 0.121 | 0.056 | -0.353 | |
| Price To Earnings Diluted Ratio | 15.543 | 10.954 | 8.022 | 9.021 | 15.473 | |
| Price To Earnings Diluted Growth Ratio | -1.067 | -0.316 | 0.133 | 0.056 | -0.353 | |
| Price To Book Ratio | 1.085 | 0.976 | 1.140 | 0.948 | 0.685 | |
| Price To Sales Ratio | 0.627 | 0.476 | 0.443 | 0.292 | 0.223 | |
| Price To Free Cash Flow Ratio | 89.540 | 6.086 | 6.155 | 45.982 | 70.223 | |
| Price To Operating Cash Flow Ratio | 8.947 | 4.090 | 4.547 | 5.799 | 5.468 | |
| Debt To Assets Ratio | 0.144 | 0.113 | 0.108 | 0.131 | 0.159 | |
| Debt To Equity Ratio | 0.208 | 0.161 | 0.165 | 0.224 | 0.296 | |
| Debt To Capital Ratio | 0.172 | 0.139 | 0.142 | 0.183 | 0.228 | |
| Long Term Debt To Capital Ratio | 0.163 | 0.118 | 0.134 | 0.165 | 0.175 | |
| Financial Leverage Ratio | 1.442 | 1.422 | 1.536 | 1.710 | 1.865 | |
| Working Capital Turnover Ratio | 4.046 | 4.922 | 8.266 | 14.526 | 14.445 | |
| Operating Cash Flow Ratio | 0.561 | 0.958 | 0.754 | 0.374 | 0.236 | |
| Operating Cash Flow Sales Ratio | 0.070 | 0.116 | 0.097 | 0.050 | 0.041 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.100 | 0.672 | 0.739 | 0.126 | 0.078 | |
| Debt Service Coverage Ratio | 10.789 | 14.049 | 13.815 | 5.018 | 1.742 | |
| Interest Coverage Ratio | 120.492 | 179.516 | 26.248 | 8.342 | 4.789 | |
| Short Term Operating Cash Flow Coverage Ratio | 9.246 | 19.378 | 23.734 | 6.179 | 1.499 | |
| Operating Cash Flow Coverage Ratio | 0.584 | 1.483 | 1.516 | 0.728 | 0.424 | |
| Capital Expenditure Coverage Ratio | 1.111 | 3.050 | 3.829 | 1.144 | 1.084 | |
| Dividend Paid And Capex Coverage Ratio | 1.111 | 3.050 | 3.829 | 1.144 | 1.084 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 6.131 | 4.058 | 3.966 | 4.610 | 4.030 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 17.4% | ▼-0.2% | ▲1.3% |
| Ebit Margin | 5.4% | ▼-0.4% | ▲0.1% |
| Ebitda Margin | 9.9% | ▼-0.3% | ▲0.7% |
| Operating Profit Margin | 5.2% | ▼-0.3% | ▼-0.1% |
| Pretax Profit Margin | 5.4% | ▼-0.4% | ▲0.3% |
| Continuous Operations Profit Margin | 4.1% | ▼-0.3% | ▲0.3% |
| Net Profit Margin | 4.1% | ▼-0.3% | ▲0.3% |
| Bottom Line Profit Margin | 4.1% | ▼-0.3% | ▲0.3% |
| Current Ratio | 3.024 | ▲0.221 | ▲0.812 |
| Quick Ratio | 2.447 | ▲0.144 | ▲0.735 |
| Solvency Ratio | 0.337 | ▼-0.093 | ▼-0.002 |
| Cash Ratio | 1.114 | ▼-0.025 | ▲0.519 |
| Price To Earnings Ratio | 15.305 | ▲4.495 | ▲3.620 |
| Price To Earnings Growth Ratio | -1.064 | ▼-0.759 | ▼-0.755 |
| Forward Price To Earnings Growth Ratio | -1.064 | ▼-0.759 | ▼-0.755 |
| Price To Earnings Diluted Ratio | 15.543 | ▲4.589 | ▲3.740 |
| Price To Earnings Diluted Growth Ratio | -1.067 | ▼-0.750 | ▼-0.757 |
| Price To Book Ratio | 1.085 | ▲0.110 | ▲0.118 |
| Price To Sales Ratio | 0.627 | ▲0.151 | ▲0.215 |
| Price To Free Cash Flow Ratio | 89.540 | ▲83.454 | ▲45.943 |
| Price To Operating Cash Flow Ratio | 8.947 | ▲4.857 | ▲3.176 |
| Debt To Assets Ratio | 0.144 | ▲0.031 | ▲0.013 |
| Debt To Equity Ratio | 0.207 | ▲0.047 | ▼-0.003 |
| Debt To Capital Ratio | 0.172 | ▲0.033 | ▼-0.001 |
| Long Term Debt To Capital Ratio | 0.163 | ▲0.045 | ▲0.012 |
| Financial Leverage Ratio | 1.442 | ▲0.020 | ▼-0.153 |
| Working Capital Turnover Ratio | 4.046 | ▼-0.876 | ▼-5.195 |
| Operating Cash Flow Ratio | 0.561 | ▼-0.396 | ▼-0.015 |
| Operating Cash Flow Sales Ratio | 0.070 | ▼-0.046 | ▼-0.005 |
| Free Cash Flow Operating Cash Flow Ratio | 0.100 | ▼-0.572 | ▼-0.243 |
| Debt Service Coverage Ratio | 10.789 | ▼-3.259 | ▲1.707 |
| Interest Coverage Ratio | 120.492 | ▼-59.025 | ▲52.614 |
| Short Term Operating Cash Flow Coverage Ratio | 9.246 | ▼-10.132 | ▼-2.761 |
| Operating Cash Flow Coverage Ratio | 0.584 | ▼-0.899 | ▼-0.363 |
| Capital Expenditure Coverage Ratio | 1.111 | ▼-1.939 | ▼-0.933 |
| Dividend Paid And Capex Coverage Ratio | 1.111 | ▼-1.939 | ▼-0.933 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 6.131 | ▲2.074 | ▲1.572 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $171.6M | $143.8M | $158.4M | $110.1M | $68.6M | |
| Enterprise value | $166.4M | $125.7M | $157.3M | $132.0M | $92.1M | |
| EV / Sales | 0.61x | 0.42x | 0.44x | 0.35x | 0.30x | |
| EV / Op. cash flow | 8.67x | 3.58x | 4.51x | 6.95x | 7.34x | |
| EV / Free cash flow | 86.81x | 5.32x | 6.11x | 55.12x | 94.25x | |
| EV / EBITDA | 6.13x | 4.06x | 3.97x | 4.61x | 4.03x | |
| Net debt / EBITDA | -0.19x | -0.58x | -0.03x | 0.76x | 1.03x | |
| Current ratio | 3.02x | 2.80x | 2.23x | 1.59x | 1.42x | |
| Income quality | 6.22x | 2.64x | 1.71x | 1.56x | 2.69x | |
| Graham number | $23 | $24 | $29 | $21 | $13 | |
| Graham net-net | $1 | $2 | -$0 | -$4 | -$5 | |
| Tax burden | 76.3% | 76.1% | 78.9% | 83.7% | 52.4% | |
| Interest burden | 99.2% | 99.5% | 96.2% | 87.1% | 79.4% | |
| Working capital | $69.2M | $66.2M | $56.7M | $29.9M | $22.1M | |
| Invested capital | $191.4M | $170.9M | $165.1M | $143.2M | $130.5M | |
| Return on assets | 4.9% | 6.3% | 9.5% | 6.1% | 2.5% | |
| Operating ROA | 6.5% | 7.9% | 12.9% | 9.3% | 6.3% | |
| Return on tangible assets | 5.4% | 7.1% | 10.7% | 7.0% | 2.9% | |
| Return on equity | 7.1% | 9.0% | 14.6% | 10.5% | 4.7% | |
| Return on invested capital | 5.5% | 7.2% | 12.4% | 10.0% | 4.1% | |
| Return on capital employed | 7.3% | 9.7% | 15.9% | 12.2% | 8.3% | |
| Earnings yield | 6.5% | 9.2% | 12.8% | 11.1% | 6.8% | |
| Free cash flow yield | 1.1% | 16.4% | 16.2% | 2.2% | 1.4% | |
| Capex / Op. cash flow | 90.0% | 32.8% | 26.1% | 87.4% | 92.2% | |
| Capex / Depreciation | 139.8% | 86.0% | 70.5% | 139.6% | 99.6% | |
| Capex / Sales | 6.3% | 3.8% | 2.5% | 4.4% | 3.8% | |
| SG&A / Sales | 12.2% | 12.1% | 10.6% | 9.1% | 9.8% | |
| R&D / Sales | 0.0% | 0.0% | 0.5% | 0.0% | 0.4% | |
| Stock comp / Sales | 0.7% | 0.8% | 0.8% | 0.6% | 0.6% | |
| Intangibles / Total assets | 9.1% | 10.4% | 11.0% | 12.6% | 14.4% | |
| Days sales outstanding | 50d | 43d | 49d | 45d | 45d | |
| Days payables outstanding | 24d | 25d | 30d | 33d | 31d | |
| Operating cycle | 82d | 70d | 77d | 72d | 79d | |
| Cash conversion cycle | 58d | 45d | 47d | 39d | 48d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+19.4%EV / Sales ▲+46.2%EV / EBITDA ▲+51.1%EV / Op. cash flow ▲+5.099Earnings yield ▼-0.027Graham number ▼-0.840
Profitability
Return on equity ▼-0.019Return on assets ▼-0.014Return on invested capital ▼-0.017Return on capital employed ▼-0.023Operating ROA ▼-0.014Income quality ▲+3.580Tax burden ▲+0.002
Efficiency
Days sales outstanding ▲+6.501Days payables outstanding ▼-0.996Operating cycle ▲+11.431Cash conversion cycle ▲+12.428Capex / Sales ▲+0.025R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.221Net debt / EBITDA ▲+0.392Working capital ▲+2978000.000Invested capital ▲+20542000.000Intangibles / Total assets ▼-0.013
Change over 5 years
Valuation
Market cap ▲+150.2%EV / Sales ▲+103.0%EV / EBITDA ▲+52.1%EV / Op. cash flow ▲+1.335Earnings yield ▼-0.003Graham number ▲+10.593
Profitability
Return on equity ▲+0.024Return on assets ▲+0.024Return on invested capital ▲+0.015Return on capital employed ▼-0.010Operating ROA ▲+0.002Income quality ▲+3.537Tax burden ▲+0.239
Efficiency
Days sales outstanding ▲+4.911Days payables outstanding ▼-7.045Operating cycle ▲+2.258Cash conversion cycle ▲+9.303Capex / Sales ▲+0.025R&D / Sales ▼-0.004
Balance-sheet strength
Current ratio ▲+1.607Net debt / EBITDA ▼-1.220Working capital ▲+47065000.000Invested capital ▲+60937000.000Intangibles / Total assets ▼-0.053
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-12 Core Molding Technologies to Host Investor Day on September 29-30, 2026, Including Tour of Matamoros, Mexico Manufacturing Facility COLUMBUS, Ohio, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in medium- and heavy-duty trucks, powersports, building products, and industrial and utility industries across North America, announced today that it will host an Investor Event on Tuesday afternoon September 29th in Brownsville, Texas. On Wednesday morning, September 30th, a tour of the Company''s Matamoros, Mexico manufacturing facility before returning to Brownsville, Texas.
- 2026-08-09 Core Molding Technologies Q2 Earnings Call Highlights Core Molding Technologies NYSEAMERICAN: CMT reported fiscal 2026 second-quarter production sales that declined 1.2% year over year as continued weakness in the medium- and heavy-duty truck market offset growth in several other end markets. Management reiterated its full-year outlook, including expectations for sales ranging from flat to up approximately 5%.
- 2026-08-04 Core Molding Technologies, Inc. (CMT) Q2 2026 Earnings Call Transcript Core Molding Technologies, Inc. (CMT) Q2 2026 Earnings Call Transcript
- 2026-08-04 Core Molding Technologies (CMT) Q2 Earnings Match Estimates Core Molding Technologies (CMT) came out with quarterly earnings of $0.21 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.47 per share a year ago.
- 2026-08-04 Core Molding Technologies Reports Fiscal 2026 Second Quarter Results COLUMBUS, Ohio, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in medium- and heavy-duty truck, powersports, building products, and industrial and utilities industries across the United States, Canada and Mexico today reports financial and operating results for the fiscal periods ended June 30, 2026. Eric Palomaki, the Company''s President and Chief Executive Officer, said, “Our second quarter results reflect the resilience of our diversified portfolio and the continued execution of our Invest for Growth strategy.
- 2026-08-03 Western Union Q2 Earnings Miss Estimates on CMT Retail Weakness WU''s Q2 earnings miss estimates as Consumer Money Transfer retail weakness and higher expenses hurt margins, even as digital and consumer services show growth.
- 2026-07-23 Time To Shine For CMT Preferreds The Fed''s recent hawkish pivot sharply increased interest rates, negatively impacting most income sectors. CMT preferreds emerge as a compelling sub-sector, offering potential protection against rising long-term rates. Screening CMT preferreds by reset yield and yield-to-call can help identify attractive opportunities.
- 2026-07-14 Core Molding Technologies Announces Timing of Its Fiscal 2026 Second Quarter Results COLUMBUS, Ohio, July 14, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in medium- and heavy-duty trucks, powersports, building products, and industrial and utility industries across North America, today announces that it will release its second quarter fiscal 2026 results on Tuesday, August 4, 2026, before the market opens. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet the same day at 10:00am Eastern.
- 2026-07-07 Core Molding Technologies Extends Credit Facility Through 2031, Increasing Financial Flexibility for Strategic Growth COLUMBUS, Ohio, July 07, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in medium- and heavy-duty truck, powersports, building products, and industrial and utility industries across the United States, Canada, and Mexico, today announced the successful amendment and extension of its credit agreement through 2031. The amended credit facility consists of a $50 million delayed draw term loan and a $50 million revolving credit facility.
- 2026-06-17 SYNAPSE-CMT Phase 2a Clinical Study Data Presented in Late-Breaking Oral Presentation at 2026 PNS Annual Meeting Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announces that further safety and efficacy data from its Phase 2a SYNAPSE-CMT exploratory study evaluating ignaseclant in patients living with Charcot-Marie-Tooth disease (CMT) types 1 or 2 has been presented in a late-breaking oral presentation at the 2026 Peripheral Neuroscience Association (PNS) Annual Meeting held in Maastricht, The Netherlands from June 13-16, 2026. The late-breaking presentation was given by David Herrmann, MD, Chief of the Neuromuscular Division and Vice Chair for Strategic Initiatives in the Department of Neurology at the University of Rochester Medical Center on Sunday, June 14, 2026.